Trial Profile
A prospective study of paricalcitol in kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Pharmacodynamics; Proof of concept
- 29 Sep 2016 New trial record